trans R-138727MP-d3, (Prasugrel Metabolite Derivative) MF: C27H25D3FNO5S
MW: 500.60
An irreversible P2Y12 inhibitor.

trans R-138727MP-d3, (Prasugrel Metabolite Derivative)

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 103ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Application: trans R-138727MP-d3, (Prasugrel Metabolite Derivative) is An irreversible P2Y12 inhibitor
Molecular Weight: 500.60
Molecular Formula: C27H25D3FNO5S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).
loading

trans R-138727MP-d3, (Prasugrel Metabolite Derivative) is a mixture of diastereomers. The active labeled metabolite derivative of Prasugrel that inhibits P2Y12 receptors, stopping signal transduction and inhibiting platelet aggregation. Binding to receptors is irreversible.


References

1. Ekins, S., et al. 1998. J. Pharmacol. Exp. Ther. 286: 1253-1259. PMID: 9732386
2. Lamba, V., et al. 2003. J. Pharmacol Exp. Ther. 307: 906-922. PMID: 14551287
3. Yoneda, K., et al. 2004. Br. J. Pharmacol. 142: 551-557. PMID: 15148251
4. Jakubowski, J., et al. 2006 J. Cardiovasc. Pharmacol. 47: 377-384. PMID: 16633079

For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 89ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 6ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;